News & Updates
  • Home
  • About Us
  • Contact
  • Home 1
  • News & Updates

    Patented New ISO Name Approved – December 2025: Triflupyroxazin, A New N-phenylimide Herbicide From Liaoning Cynda Chemical Co., Ltd.

    Patented New ISO Name Approved – December 2025: Amfenamacril, A New Aminocyanoacrylate Fungicide From Jiangsu Pesticide Research Institute Co., Ltd.

    Delhi HC refuses FMC’s plea to stop Natco’s Cyantraniliprole commercialization

    FDA Pushes Pfizer COVID Vaccine for 6 Month to 5 Years Kids

    adminFebruary 7, 202201.7k views

    Summary : A good news is brewing for kids as the COVID-19 vaccine for the age group younger than 5 years old…

    Read more

    Fast Radius Announces Completion of Merger with ECP Environmental Growth Opportunities Corp.

    adminFebruary 6, 202201.6k views

    Summary : Fast Radius will trade on Nasdaq under ticker symbol “FSRD” “Fast Radius”), a cloud manufacturing company, today announced the successful…

    Read more

    ION receives continued listing standard notice from the NYSE

    adminFebruary 5, 202201.6k views

    Synopsis : ION Geophysical Corporation (NYSE: IO) today announced that it received notice on January 31, 2022 from the New York Stock…

    Read more

    FDA approves Enjaymo™ (sutimlimab-jome), First Treatment for use in Patients with Cold Agglutinin Disease

    adminFebruary 5, 202202.4k views

    Summary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment…

    Read more

    Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    adminFebruary 5, 202201.6k views

    Synopsis : Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative…

    Read more

    Sanofi Unites as One Under New Logo, Structure

    adminFebruary 5, 202202.1k views

    Synopsis : Sanofi has been a global healthcare leader that has brought forth treatments for rare diseases and established standard-of-care therapeutics for…

    Read more

    Financials Indicate Novartis’ Sandoz Division Could Be a Tough Sell

    adminFebruary 5, 202201.8k views

    Synopsis : Novartis reported its full-year financials this week for 2021, and overall, the news was good. Full-year net sales grew 4%,…

    Read more

    Biogen’s Aduhelm Grabs the Spotlight at User Fee Renewals Hearing

    adminFebruary 5, 202201.7k views

    Summary – The House Energy and Commerce Committee’s health panel met to discuss renewing user fee agreements used to fund the U.S.…

    Read more

    Valneva and Pfizer report further positive Phase 2 data for Lyme disease vaccine candidate

    adminFebruary 5, 202201.7k views

    Synopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive…

    Read more

    Three exposures to spike protein allow people to develop broad antibody immunity – also against Omicron

    adminFebruary 5, 202201.5k views

    Summary : Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is…

    Read more

    Posts navigation

    1 … 49 … 105
    View Desktop Version

    Powered by PenciDesign

    Back To Top